From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

KEFI

Kefi formalises ownership structure of Tulu Kapi - buy, upside still 100%+

This was a done deal for ages but now it has been formalised. It's another box tick to building the mine at Tulu Kapi...

EDEN
premium content

Eden – a question from the Deputy Sheriff to m’learned friends of the ShareProphets community

Noting recent coverage of AIM-listed Eden Research (EDEN) and its, ahem, “interesting” funding arrangements with Terpenetech here on ShareProphets I have a question: given that it appears that Eden is the only holder of paid-up shares in Terpenetech, does that not mean that Eden holds the only (currently) valid voting rights? And if that is the case, is not Eden in fact the ultimate controlling party? And if that is the case, should Terpenetech be viewed as a 100% owned and controlled entity of Eden - a subsidiary, therefore, and have to release full audited accounts?

AVO

Reader Poll results: Advanced Oncotherapy share plunge - when will it hit 0p?

ShareProphets readers don't expect an immediate implosion on Advanced Oncotherapy (AVO). They're leaving it to Father Christmas to do the job. We asked you when the shares would hit 0p - you said!

SPA

Buy 1Spatial, target 6p+

1Spatial (SPA) is a spatial data and IT managed services-focused company the team here has followed for a while. The shares rose from sub 2p in 2012 to reach more than 10p in early 2014, before sliding back to circa 5p in 2016 - and declining further post an 18th October announcement of results for the half year ended 31st July 2016. However, since early March a share price recovery has been in progress – and we are confident that there is more to come from here…

AVO
premium content

Advanced Oncotherapy – Oh to be a fly on the wall as it discusses Going Concern with auditor. Will it get its accounts out on time?

AIM-listed Advanced Oncotherapy (AVO) has a calendar year-end and as such its six-month deadline to publish accounts falls on 30 June – the end of next month. That means getting an audit done which will involve, amongst other things, agreeing the Going Concern statement. Yesterday’s share price plunge might have more than a small bearing on how conversations go in that regard.

FLX

Falanx - placing and trading statement: shares go up! We upgrade (again)

How often do you see a small AIM company raise a good whack of money relative to its market cap (in this case the new shares issued are just under 20% of the enlarged total) and still see its shares go up on the day? Once in a blue moon. Well it has happened with Falanx (FLX), whose shares closed at 7.5p-8p.

Newsboy

Notes from Underground: All's quiet on the ShareProphets front

The first non-Tom Winnifrith (and non-house) article is #1, Sepura – The rollercoaster deal continues: could this be the first Brexit-related deal implosion? by Cynical Bear. We may have turned a corner, folks.

RDT

New Bulletin Board Moron of the Week Contest - sponsored by Rosslyn Data

The old-bailout-disguised-as-acquisition switcheroo demonstates that Rosslyn Data (RDT) has what it takes to be a Bulletin Board Moron of the Week sponsor.

AFPO
premium content

African Potash - update on legal action against those who facilitated this fraud

As you know I have been keen to ensure that all those who cost investors millions of pounds in facilitating the fraud that was African Potash (AFPO) face justice. Thus I have been pushing to assist those who did lose to get some of their cash back with a legal case against the Nomad Cantor Fitzgerald. The man in charge of that is Peter Petyt who has just sent an update to those who have contacted him. If you lost money and want to get on board it is NOT to late. Peter writes...

CTAG
premium content

Photo Article: Cloudtag - FD walks but don't worry new NED arrives

What's not to like? No Listing after being booted off AIM because no Nomad would sign off on its lies. No product for sale. Almost no cash left. And now the Finance Director of the fraud Cloudtag (CTAG) has quit. More red flags for tea vicar?

AVO

Advanced Oncotherapy share plunge - when will it hit 0p? Reader Poll

Shares in AIM dog Advanced Oncotherapy (AVO) closed Friday at just 21p. That is below the 25p nominal meaning that death spiral provider Bracknor cannot convert any more loan notes without taking a huge loss and, if that continues, it means the company will go tits up in the summer. Or the former Malcolm Stacey darling will need to approve a capital reconstruction to set a new nominal (2.5p?) which will see the shares plunge, so meaning Bracknor physically can't convert loan notes so Advanced will go tits up this summer. So when will its shares hit 0p or be suspended from AIM? Vote now in our reader poll - deadline midnight tonight.

SND

Sanderson Group – half-year trading update, “in line” & confident

November addition to the Nifty Fifty Growth portfolio, Sanderson Group (SND) has updated on half-year ended 31st March 2017 trading “in line with management's expectations” and on a “good level of confidence that the group will continue to make further progress during the current financial year”

FPM

Table of shorted AIM shares - week to 05/05/2017

From the FCA's spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2016 and thus far in 2017 (by net short position %) - and if this position has increased (red), reduced (green) or remained unchanged (black) since last week...

EDEN
premium content

Terpenetech & the Eden Research fraud, fraud, fraud: Part 2

Yesterday we saw demonstrable and explicit evidence that AIM Cesspit fraud Eden Research (EDEN) had committed a panama pump stock fraud with its 29.9% owned associate Terpenetech, HERE. But it seems that I was too charitable in my assessment of Terpenetech's laughable accounts. A hat tip to reader CS who points out:

Gold

Targeting a Summer Low for gold - perma bulls warn of short term weakness

Perma bull of gold and precious metals Palisade Capital seems to have become a bit less bullish, indeed it warns of a summer sell-off in the latest video with chartist Jordan Roy-Byrne.

RDSA

Here's What You Might Do, as the Price of Ebony Nectar Wobbles Down

Hello Share Grinders. Unusually for me, I’m a little pessimistic this weekend. And the cause - a very weak oil price. This is a big disappointment, as the signs a few months ago were that the price of the ebony nectar was on the rise.

Wray
premium content

Lucy Wray: UK Investor 2017 the biggest & most exciting yet - Great reasons to book NOW for April 21 2018!

UK Investor Show 2017 was three weeks ago and was our biggest event yet. The 15th anniversary party got rave reviews from attendees. But fear not the 16th show , UK Investor 2018 on April 21 will be even bigger and better and there are compelling reasons to book your seats NOW.

FITB

Goodbye jam-tomorrow entity Fitbug Holdings Plc. Hello, er, jam-tomorrow entity, Kin Group Plc

Fitbug Holdings (FITB) has updated that all resolutions were passed at its AGM today – including meaning it’s soon goodbye the jam-tomorrow entity that is Fitbug Holdings Plc and hello a, er, jam-tomorrow entity that is to be Kin Group Plc...

EDEN
premium content

Terpenetech Accounts filed - the panama pump fraud at AIM listed Eden confirmed

The fraud is confirmed. Will Eden Research's (EDEN) Nomad Shore cap resign? Will Eden impair the carrying value of Terpenetech which appears to be insolvent? Does anyone care any more?

Election_2017
premium content

Local Elections - UKIP toast, Lib & Labour disaster - Tories slam dunk certs for June 8

You can always dismiss local elections as local contests which tell you nothing about the result of the next General Election. But when that next General Election is just five weeks away and when there are clear trends evident across the board you can make clear assumptions. Let's start with UKIP whose spokesperson Lisa Duffy said the results were "disappointing" but she would "not call it a disaster". As I write the fruitcakes have lost 98 of the 99 seats they were defending and not gained one. If that is not a disaster what is? UKIP is finished. And its votes have clearly gone Conservative.

Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

 

ANP

Anpario – a recovery Buy?...

Thursday »

Cat_Fixing_Lightbulb

Bearcast issue update: all should be well

 

ORCP

Oracle Power: Cynical Foul

Time left: 17:23:23